Last 12 months
Inside the activity.
2 purchase rows · 101 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 7 |
| Dec 2025 | 0 | 16 |
| Jan 2026 | 0 | 7 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 2 | 3 |
| Apr 2026 | 0 | 5 |
| May 2026 | 0 | 13 |
| Jun 2026 | 0 | 19 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 24 |
| Oct 2026 | 0 | 3 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 01, 2024 Filed Feb 5, 2024 16:00 UTC |
ZUK NIRDirector · EVP, Chief Technology Officer
|
SaleCommon Stock | 8,507 | $338.63 | $2,880,725.41 |
DisclosureSEC source: 0000950170-24-011222 · ownership.xml · nonDerivative · entry 3 ZUK NIR · CIK 0001250333 · Director · EVP, Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,418,478 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2023. F4 · price: This sale price represents the weighted average sale price of the shares sold ranging from $338.09 to $339.08 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| February 01, 2024 Filed Feb 5, 2024 16:00 UTC |
ZUK NIRDirector · EVP, Chief Technology Officer
|
SaleCommon Stock | 9,231 | $337.50 | $3,115,490.19 |
DisclosureSEC source: 0000950170-24-011222 · ownership.xml · nonDerivative · entry 2 ZUK NIR · CIK 0001250333 · Director · EVP, Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,426,985 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2023. F3 · price: This sale price represents the weighted average sale price of the shares sold ranging from $337.09 to $338.075 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| February 01, 2024 Filed Feb 5, 2024 16:00 UTC |
ZUK NIRDirector · EVP, Chief Technology Officer
|
SaleCommon Stock | 3,351 | $336.72 | $1,128,342.02 |
DisclosureSEC source: 0000950170-24-011222 · ownership.xml · nonDerivative · entry 1 ZUK NIR · CIK 0001250333 · Director · EVP, Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,436,216 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2023. F2 · price: This sale price represents the weighted average sale price of the shares sold ranging from $336.09 to $337.08 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| January 29, 2024 Filed Jan 31, 2024 21:50 UTC |
Klarich LeeEVP, Chief Product Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 45,000 | $0.00 Strike: $64.50 | $0.00 |
DisclosureSEC source: 0000950170-24-009456 · ownership.xml · derivative · entry 8 Klarich Lee · CIK 0001682260 · EVP, Chief Product Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,472,079 Underlying: Common Stock · 45,000 shares Expires 2028-10-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable. Read SEC document |
| January 29, 2024 Filed Jan 31, 2024 21:50 UTC |
Klarich LeeEVP, Chief Product Officer
|
SaleCommon Stock | 2,428 | $345.01 | $837,684.28 |
DisclosureSEC source: 0000950170-24-009456 · ownership.xml · nonDerivative · entry 6 Klarich Lee · CIK 0001682260 · EVP, Chief Product Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 198,105 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 20, 2022. F6 · price: This sale price represents the weighted average sale price of the shares sold ranging from $344.89 to $345.46 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| January 29, 2024 Filed Jan 31, 2024 21:50 UTC |
Klarich LeeEVP, Chief Product Officer
|
SaleCommon Stock | 8,700 | $344.31 | $2,995,505.70 |
DisclosureSEC source: 0000950170-24-009456 · ownership.xml · nonDerivative · entry 5 Klarich Lee · CIK 0001682260 · EVP, Chief Product Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,533 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 20, 2022. F5 · price: This sale price represents the weighted average sale price of the shares sold ranging from $343.89 to $344.725 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| January 29, 2024 Filed Jan 31, 2024 21:50 UTC |
Klarich LeeEVP, Chief Product Officer
|
SaleCommon Stock | 11,191 | $343.38 | $3,842,743.20 |
DisclosureSEC source: 0000950170-24-009456 · ownership.xml · nonDerivative · entry 4 Klarich Lee · CIK 0001682260 · EVP, Chief Product Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 209,233 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 20, 2022. F4 · price: This sale price represents the weighted average sale price of the shares sold ranging from $342.89 to $343.85 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| January 29, 2024 Filed Jan 31, 2024 21:50 UTC |
Klarich LeeEVP, Chief Product Officer
|
SaleCommon Stock | 15,781 | $342.44 | $5,403,998.30 |
DisclosureSEC source: 0000950170-24-009456 · ownership.xml · nonDerivative · entry 3 Klarich Lee · CIK 0001682260 · EVP, Chief Product Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 220,424 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 20, 2022. F3 · price: This sale price represents the weighted average sale price of the shares sold ranging from $341.89 to $342.885 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| January 29, 2024 Filed Jan 31, 2024 21:50 UTC |
Klarich LeeEVP, Chief Product Officer
|
SaleCommon Stock | 6,900 | $341.51 | $2,356,398.30 |
DisclosureSEC source: 0000950170-24-009456 · ownership.xml · nonDerivative · entry 2 Klarich Lee · CIK 0001682260 · EVP, Chief Product Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 236,205 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 20, 2022. F2 · price: This sale price represents the weighted average sale price of the shares sold ranging from $340.89 to $341.87 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| January 29, 2024 Filed Jan 31, 2024 21:50 UTC |
Klarich LeeEVP, Chief Product Officer
|
Exercise / conversionCommon Stock | 45,000 | $64.50 | $2,902,648.50 |
DisclosureSEC source: 0000950170-24-009456 · ownership.xml · nonDerivative · entry 1 Klarich Lee · CIK 0001682260 · EVP, Chief Product Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 243,105 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 20, 2024 Filed Jan 23, 2024 22:08 UTC |
Klarich LeeEVP, Chief Product Officer
|
Tax withholdingCommon Stock | 7,112 | $337.74 | $2,402,006.88 |
DisclosureSEC source: 0000950170-24-006635 · ownership.xml · nonDerivative · entry 1 Klarich Lee · CIK 0001682260 · EVP, Chief Product Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 198,105 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported performance-based restricted stock units. F2 · balance_after: This number corrects a previous report wherein a gift disposition by the Lee and Susan Klarich 2005 Trust dtd 12/05/2005 ("Klarich 2005 Trust") was inadvertently reported as coming from the Reporting Person's direct holdings. Read SEC document |
| January 20, 2024 Filed Jan 24, 2024 01:19 UTC |
Arora NikeshDirector · Chief Executive Officer
|
GrantPhantom Stock · Derivative | 54,228 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-006775 · ownership.xml · derivative · entry 3 Arora Nikesh · CIK 0001468233 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 502,418 Underlying: Common Stock · 54,228 shares Expires not disclosed F1 · derivative.exercise_price: In connection with the vesting of previously reported performance-based restricted stock units, the Reporting Person elected to defer these shares pursuant to the Palo Alto Networks, Inc. Deferred Compensation Plan (the "Deferred Compensation Plan"). F3 · derivative.exercise_price: Pursuant to the Deferred Compensation Plan, each share of phantom stock represents the Reporting Person's right to receive one share of common stock of the Issuer. The common stock shares will be released on or about January 31, 2027. F1 · derivative.exercise_date: In connection with the vesting of previously reported performance-based restricted stock units, the Reporting Person elected to defer these shares pursuant to the Palo Alto Networks, Inc. Deferred Compensation Plan (the "Deferred Compensation Plan"). F3 · derivative.exercise_date: Pursuant to the Deferred Compensation Plan, each share of phantom stock represents the Reporting Person's right to receive one share of common stock of the Issuer. The common stock shares will be released on or about January 31, 2027. F1 · derivative.expiration_date: In connection with the vesting of previously reported performance-based restricted stock units, the Reporting Person elected to defer these shares pursuant to the Palo Alto Networks, Inc. Deferred Compensation Plan (the "Deferred Compensation Plan"). F3 · derivative.expiration_date: Pursuant to the Deferred Compensation Plan, each share of phantom stock represents the Reporting Person's right to receive one share of common stock of the Issuer. The common stock shares will be released on or about January 31, 2027. Read SEC document |
| January 20, 2024 Filed Jan 24, 2024 01:19 UTC |
Arora NikeshDirector · Chief Executive Officer
|
Disposition to issuerCommon Stock | 54,228 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-006775 · ownership.xml · nonDerivative · entry 1 Arora Nikesh · CIK 0001468233 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 790,888 F1 · kind: In connection with the vesting of previously reported performance-based restricted stock units, the Reporting Person elected to defer these shares pursuant to the Palo Alto Networks, Inc. Deferred Compensation Plan (the "Deferred Compensation Plan"). Read SEC document |
| January 16, 2024 Filed Jan 16, 2024 22:23 UTC |
Donovan JohnDirector
|
SaleCommon Stock | 3,000 | $330.01 | $990,021.00 |
DisclosureSEC source: 0000950170-24-004732 · ownership.xml · nonDerivative · entry 4 Donovan John · CIK 0001353825 · Director 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 30,352 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 8, 2023. F7 · price: This sale price represents the weighted average sale price of the shares sold ranging from $330.00 to $330.06 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. F5 · ownership.nature: Shares held by SRJ Norway II Partners LP, for which the Reporting Person serves as general partner. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. Read SEC document |
| January 16, 2024 Filed Jan 16, 2024 22:23 UTC |
Donovan JohnDirector
|
SaleCommon Stock | 5,100 | $330.05 | $1,683,265.20 |
DisclosureSEC source: 0000950170-24-004732 · ownership.xml · nonDerivative · entry 3 Donovan John · CIK 0001353825 · Director 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 52,605 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 8, 2023. F6 · price: This sale price represents the weighted average sale price of the shares sold ranging from $330.00 to $330.26 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. F3 · ownership.nature: Shares held by The Donovan Family Living Trust U/A DTD 09/28/2012, for which the Reporting Person serves as co-trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. Read SEC document |
| January 12, 2024 Filed Jan 16, 2024 22:23 UTC |
Donovan JohnDirector
|
SaleCommon Stock | 3,500 | $330.00 | $1,155,010.50 |
DisclosureSEC source: 0000950170-24-004732 · ownership.xml · nonDerivative · entry 2 Donovan John · CIK 0001353825 · Director 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 33,352 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 8, 2023. F4 · price: This sale price represents the weighted average sale price of the shares sold ranging from $330.00 to $330.09 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. F5 · ownership.nature: Shares held by SRJ Norway II Partners LP, for which the Reporting Person serves as general partner. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. Read SEC document |
| January 12, 2024 Filed Jan 16, 2024 22:23 UTC |
Donovan JohnDirector
|
SaleCommon Stock | 3,500 | $330.05 | $1,155,178.50 |
DisclosureSEC source: 0000950170-24-004732 · ownership.xml · nonDerivative · entry 1 Donovan John · CIK 0001353825 · Director 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 57,705 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 8, 2023. F2 · price: This sale price represents the weighted average sale price of the shares sold ranging from $330.00 to $330.12 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. F3 · ownership.nature: Shares held by The Donovan Family Living Trust U/A DTD 09/28/2012, for which the Reporting Person serves as co-trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. Read SEC document |
| January 09, 2024 Filed Jan 10, 2024 23:09 UTC |
Donovan JohnDirector
|
SaleCommon Stock | 6,500 | $300.06 | $1,950,366.60 |
DisclosureSEC source: 0001209191-24-001392 · doc4.xml · nonDerivative · entry 14 Donovan John · CIK 0001353825 · Director 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 36,852 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 8, 2023. F17 · price: This sale price represents the weighted average sale price of the shares sold ranging from $300.00 to $300.20 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. F10 · ownership.nature: Shares held by SRJ Norway II Partners LP, for which the Reporting Person serves as general partner. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. In the Reporting Person's previous Section 16 reports, these securities were reported as being held by SRJ Norway Partners LP. Read SEC document |
| January 09, 2024 Filed Jan 10, 2024 23:09 UTC |
Donovan JohnDirector
|
SaleCommon Stock | 8,600 | $300.07 | $2,580,624.36 |
DisclosureSEC source: 0001209191-24-001392 · doc4.xml · nonDerivative · entry 13 Donovan John · CIK 0001353825 · Director 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 61,205 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 8, 2023. F16 · price: This sale price represents the weighted average sale price of the shares sold ranging from $300.00 to $300.23 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. F3 · ownership.nature: Shares held by The Donovan Family Living Trust U/A DTD 09/28/2012, for which the Reporting Person serves as co-trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. In the Reporting Person's previous Section 16 reports, these securities were reported as being held by the Reporting Person. Read SEC document |
| January 08, 2024 Filed Jan 10, 2024 23:09 UTC |
Donovan JohnDirector
|
SaleCommon Stock | 200 | $290.66 | $58,131.00 |
DisclosureSEC source: 0001209191-24-001392 · doc4.xml · nonDerivative · entry 12 Donovan John · CIK 0001353825 · Director 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 43,352 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 8, 2023. F15 · price: This sale price represents the weighted average sale price of the shares sold ranging from $290.64 to $290.67 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. F10 · ownership.nature: Shares held by SRJ Norway II Partners LP, for which the Reporting Person serves as general partner. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. In the Reporting Person's previous Section 16 reports, these securities were reported as being held by SRJ Norway Partners LP. Read SEC document |
| January 08, 2024 Filed Jan 10, 2024 23:09 UTC |
Donovan JohnDirector
|
SaleCommon Stock | 3,268 | $289.68 | $946,667.70 |
DisclosureSEC source: 0001209191-24-001392 · doc4.xml · nonDerivative · entry 11 Donovan John · CIK 0001353825 · Director 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 43,552 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 8, 2023. F14 · price: This sale price represents the weighted average sale price of the shares sold ranging from $289.41 to $290.27. per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. F10 · ownership.nature: Shares held by SRJ Norway II Partners LP, for which the Reporting Person serves as general partner. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. In the Reporting Person's previous Section 16 reports, these securities were reported as being held by SRJ Norway Partners LP. Read SEC document |
| January 08, 2024 Filed Jan 10, 2024 23:09 UTC |
Donovan JohnDirector
|
SaleCommon Stock | 2,200 | $288.89 | $635,562.40 |
DisclosureSEC source: 0001209191-24-001392 · doc4.xml · nonDerivative · entry 10 Donovan John · CIK 0001353825 · Director 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 46,820 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 8, 2023. F13 · price: This sale price represents the weighted average sale price of the shares sold ranging from $288.39 to $289.37 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. F10 · ownership.nature: Shares held by SRJ Norway II Partners LP, for which the Reporting Person serves as general partner. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. In the Reporting Person's previous Section 16 reports, these securities were reported as being held by SRJ Norway Partners LP. Read SEC document |
| January 08, 2024 Filed Jan 10, 2024 23:09 UTC |
Donovan JohnDirector
|
SaleCommon Stock | 1,900 | $287.79 | $546,797.20 |
DisclosureSEC source: 0001209191-24-001392 · doc4.xml · nonDerivative · entry 9 Donovan John · CIK 0001353825 · Director 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 49,020 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 8, 2023. F12 · price: This sale price represents the weighted average sale price of the shares sold ranging from $287.32 to $288.31 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. F10 · ownership.nature: Shares held by SRJ Norway II Partners LP, for which the Reporting Person serves as general partner. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. In the Reporting Person's previous Section 16 reports, these securities were reported as being held by SRJ Norway Partners LP. Read SEC document |
| January 08, 2024 Filed Jan 10, 2024 23:09 UTC |
Donovan JohnDirector
|
SaleCommon Stock | 200 | $285.91 | $57,181.00 |
DisclosureSEC source: 0001209191-24-001392 · doc4.xml · nonDerivative · entry 8 Donovan John · CIK 0001353825 · Director 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 50,920 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 8, 2023. F11 · price: This sale price represents the weighted average sale price of the shares sold ranging from $285.72 to $286.09 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. F10 · ownership.nature: Shares held by SRJ Norway II Partners LP, for which the Reporting Person serves as general partner. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. In the Reporting Person's previous Section 16 reports, these securities were reported as being held by SRJ Norway Partners LP. Read SEC document |
| January 08, 2024 Filed Jan 10, 2024 23:09 UTC |
Donovan JohnDirector
|
SaleCommon Stock | 900 | $284.99 | $256,491.00 |
DisclosureSEC source: 0001209191-24-001392 · doc4.xml · nonDerivative · entry 7 Donovan John · CIK 0001353825 · Director 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 51,120 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 8, 2023. F9 · price: This sale price represents the weighted average sale price of the shares sold ranging from $284.57 to $285.38 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. F10 · ownership.nature: Shares held by SRJ Norway II Partners LP, for which the Reporting Person serves as general partner. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. In the Reporting Person's previous Section 16 reports, these securities were reported as being held by SRJ Norway Partners LP. Read SEC document |
| January 08, 2024 Filed Jan 10, 2024 23:09 UTC |
Donovan JohnDirector
|
SaleCommon Stock | 1,320 | $290.10 | $382,929.36 |
DisclosureSEC source: 0001209191-24-001392 · doc4.xml · nonDerivative · entry 6 Donovan John · CIK 0001353825 · Director 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 69,805 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 8, 2023. F8 · price: This sale price represents the weighted average sale price of the shares sold ranging from $289.87 to $290.64 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. F3 · ownership.nature: Shares held by The Donovan Family Living Trust U/A DTD 09/28/2012, for which the Reporting Person serves as co-trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. In the Reporting Person's previous Section 16 reports, these securities were reported as being held by the Reporting Person. Read SEC document |
| January 08, 2024 Filed Jan 10, 2024 23:09 UTC |
Donovan JohnDirector
|
SaleCommon Stock | 5,404 | $289.36 | $1,563,723.06 |
DisclosureSEC source: 0001209191-24-001392 · doc4.xml · nonDerivative · entry 5 Donovan John · CIK 0001353825 · Director 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 71,125 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 8, 2023. F7 · price: This sale price represents the weighted average sale price of the shares sold ranging from $288.87 to $289.85 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. F3 · ownership.nature: Shares held by The Donovan Family Living Trust U/A DTD 09/28/2012, for which the Reporting Person serves as co-trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. In the Reporting Person's previous Section 16 reports, these securities were reported as being held by the Reporting Person. Read SEC document |
| January 08, 2024 Filed Jan 10, 2024 23:09 UTC |
Donovan JohnDirector
|
SaleCommon Stock | 2,600 | $288.32 | $749,629.40 |
DisclosureSEC source: 0001209191-24-001392 · doc4.xml · nonDerivative · entry 4 Donovan John · CIK 0001353825 · Director 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 76,529 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 8, 2023. F6 · price: This sale price represents the weighted average sale price of the shares sold ranging from $287.84 to $288.83 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. F3 · ownership.nature: Shares held by The Donovan Family Living Trust U/A DTD 09/28/2012, for which the Reporting Person serves as co-trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. In the Reporting Person's previous Section 16 reports, these securities were reported as being held by the Reporting Person. Read SEC document |
| January 08, 2024 Filed Jan 10, 2024 23:09 UTC |
Donovan JohnDirector
|
SaleCommon Stock | 800 | $287.50 | $229,996.80 |
DisclosureSEC source: 0001209191-24-001392 · doc4.xml · nonDerivative · entry 3 Donovan John · CIK 0001353825 · Director 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 79,129 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 8, 2023. F5 · price: This sale price represents the weighted average sale price of the shares sold ranging from $286.83 to $287.77 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. F3 · ownership.nature: Shares held by The Donovan Family Living Trust U/A DTD 09/28/2012, for which the Reporting Person serves as co-trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. In the Reporting Person's previous Section 16 reports, these securities were reported as being held by the Reporting Person. Read SEC document |
| January 08, 2024 Filed Jan 10, 2024 23:09 UTC |
Donovan JohnDirector
|
SaleCommon Stock | 400 | $285.65 | $114,258.00 |
DisclosureSEC source: 0001209191-24-001392 · doc4.xml · nonDerivative · entry 2 Donovan John · CIK 0001353825 · Director 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 79,929 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 8, 2023. F4 · price: This sale price represents the weighted average sale price of the shares sold ranging from $285.58 to $285.68 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. F3 · ownership.nature: Shares held by The Donovan Family Living Trust U/A DTD 09/28/2012, for which the Reporting Person serves as co-trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. In the Reporting Person's previous Section 16 reports, these securities were reported as being held by the Reporting Person. Read SEC document |
| January 08, 2024 Filed Jan 10, 2024 23:09 UTC |
Donovan JohnDirector
|
SaleCommon Stock | 944 | $285.16 | $269,187.26 |
DisclosureSEC source: 0001209191-24-001392 · doc4.xml · nonDerivative · entry 1 Donovan John · CIK 0001353825 · Director 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 80,329 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 8, 2023. F2 · price: This sale price represents the weighted average sale price of the shares sold ranging from $284.57 to $285.46 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. F3 · ownership.nature: Shares held by The Donovan Family Living Trust U/A DTD 09/28/2012, for which the Reporting Person serves as co-trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. In the Reporting Person's previous Section 16 reports, these securities were reported as being held by the Reporting Person. Read SEC document |
| January 02, 2024 Filed Jan 3, 2024 18:14 UTC |
ZUK NIRDirector · EVP, Chief Technology Officer
|
SaleCommon Stock | 540 | $291.49 | $157,402.44 |
DisclosureSEC source: 0001209191-24-000519 · doc4.xml · nonDerivative · entry 7 ZUK NIR · CIK 0001250333 · Director · EVP, Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,439,567 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2023. F8 · price: This sale price represents the weighted average sale price of the shares sold ranging from $291.34 to $291.66 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| January 02, 2024 Filed Jan 3, 2024 18:14 UTC |
ZUK NIRDirector · EVP, Chief Technology Officer
|
SaleCommon Stock | 4,207 | $290.56 | $1,222,381.71 |
DisclosureSEC source: 0001209191-24-000519 · doc4.xml · nonDerivative · entry 6 ZUK NIR · CIK 0001250333 · Director · EVP, Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,440,107 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2023. F7 · price: This sale price represents the weighted average sale price of the shares sold ranging from $290.17 to $291.08 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| January 02, 2024 Filed Jan 3, 2024 18:14 UTC |
ZUK NIRDirector · EVP, Chief Technology Officer
|
SaleCommon Stock | 9,011 | $289.62 | $2,609,747.80 |
DisclosureSEC source: 0001209191-24-000519 · doc4.xml · nonDerivative · entry 5 ZUK NIR · CIK 0001250333 · Director · EVP, Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,444,314 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2023. F6 · price: This sale price represents the weighted average sale price of the shares sold ranging from $289.16 to $290.14 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| January 02, 2024 Filed Jan 3, 2024 18:14 UTC |
ZUK NIRDirector · EVP, Chief Technology Officer
|
SaleCommon Stock | 11,730 | $288.68 | $3,386,251.59 |
DisclosureSEC source: 0001209191-24-000519 · doc4.xml · nonDerivative · entry 4 ZUK NIR · CIK 0001250333 · Director · EVP, Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,453,325 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2023. F5 · price: This sale price represents the weighted average sale price of the shares sold ranging from $288.16 to $289.15 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| January 02, 2024 Filed Jan 3, 2024 18:14 UTC |
ZUK NIRDirector · EVP, Chief Technology Officer
|
SaleCommon Stock | 4,729 | $287.75 | $1,360,783.94 |
DisclosureSEC source: 0001209191-24-000519 · doc4.xml · nonDerivative · entry 3 ZUK NIR · CIK 0001250333 · Director · EVP, Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,465,055 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2023. F4 · price: This sale price represents the weighted average sale price of the shares sold ranging from $287.15 to $288.12 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| January 02, 2024 Filed Jan 3, 2024 18:14 UTC |
ZUK NIRDirector · EVP, Chief Technology Officer
|
SaleCommon Stock | 2,400 | $286.65 | $687,948.00 |
DisclosureSEC source: 0001209191-24-000519 · doc4.xml · nonDerivative · entry 2 ZUK NIR · CIK 0001250333 · Director · EVP, Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,469,784 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2023. F3 · price: This sale price represents the weighted average sale price of the shares sold ranging from $286.10 to $287.07 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| January 02, 2024 Filed Jan 3, 2024 18:14 UTC |
ZUK NIRDirector · EVP, Chief Technology Officer
|
SaleCommon Stock | 3,383 | $285.64 | $966,320.12 |
DisclosureSEC source: 0001209191-24-000519 · doc4.xml · nonDerivative · entry 1 ZUK NIR · CIK 0001250333 · Director · EVP, Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,472,184 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2023. F2 · price: This sale price represents the weighted average sale price of the shares sold ranging from $285.07 to $286.05 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| December 22, 2023 Filed Aug 31, 2024 01:00 UTC |
Bawa AparnaDirector
|
SaleCommon Stock | 5 | $298.33 | $1,491.63 |
DisclosureSEC source: 0000950170-24-102518 · ownership.xml · nonDerivative · entry 9 Bawa Aparna · CIK 0001773301 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,844 Read SEC document |
| December 20, 2023 Filed Dec 21, 2023 00:23 UTC |
Paul Josh D.Chief Accounting Officer
|
Tax withholdingCommon Stock | 982 | $308.61 | $303,055.02 |
DisclosureSEC source: 0001209191-23-059394 · doc4.xml · nonDerivative · entry 1 Paul Josh D. · CIK 0001882285 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,203 F1 · shares: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| December 20, 2023 Filed Dec 21, 2023 00:23 UTC |
Golechha DipakEVP, Chief Financial Officer
|
Tax withholdingCommon Stock | 3,310 | $308.61 | $1,021,499.10 |
DisclosureSEC source: 0001209191-23-059393 · doc4.xml · nonDerivative · entry 1 Golechha Dipak · CIK 0001852540 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,861 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units and performance-based restricted stock units. Read SEC document |
| December 18, 2023 Filed Dec 19, 2023 21:36 UTC |
Key John P.Director
|
SaleCommon Stock | 2,297 | $308.74 | $709,175.78 |
DisclosureSEC source: 0001209191-23-059167 · doc4.xml · nonDerivative · entry 1 Key John P. · CIK 0001772458 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,802 Read SEC document |
| December 13, 2023 Filed Dec 13, 2023 22:31 UTC |
Golechha DipakEVP, Chief Financial Officer
|
SaleCommon Stock | 2,500 | $305.04 | $762,600.00 |
DisclosureSEC source: 0001209191-23-058531 · doc4.xml · nonDerivative · entry 1 Golechha Dipak · CIK 0001852540 · EVP, Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 74,171 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 13, 2023. Read SEC document |
| December 12, 2023 Filed Dec 13, 2023 21:39 UTC |
Bawa AparnaDirector
|
GrantCommon Stock | 1,399 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-058490 · doc4.xml · nonDerivative · entry 1 Bawa Aparna · CIK 0001773301 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,089 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest in equal quarterly increments over a one year period, subject to the Reporting Person's continued service as of each such date. Read SEC document |
| December 12, 2023 Filed Dec 13, 2023 21:40 UTC |
Donovan JohnDirector
|
GrantCommon Stock | 1,563 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-058491 · doc4.xml · nonDerivative · entry 1 Donovan John · CIK 0001353825 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,017 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest in equal quarterly increments over a one year period, subject to the Reporting Person's continued service as of each such date. Read SEC document |
| December 12, 2023 Filed Dec 13, 2023 16:41 UTC |
Eschenbach Carl M.Director
|
GrantCommon Stock | 1,272 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-058492 · doc4.xml · nonDerivative · entry 1 Eschenbach Carl M. · CIK 0001409324 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,232 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest in equal quarterly increments over a one year period, subject to the Reporting Person's continued service as of each such date. Read SEC document |
| December 12, 2023 Filed Dec 13, 2023 21:41 UTC |
Gayle Helene DDirector
|
GrantCommon Stock | 1,308 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-058494 · doc4.xml · nonDerivative · entry 1 Gayle Helene D · CIK 0001487047 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,135 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest in equal quarterly increments over a one year period, subject to the Reporting Person's continued service as of each such date. Read SEC document |
| December 12, 2023 Filed Dec 13, 2023 21:42 UTC |
Key John P.Director
|
GrantCommon Stock | 1,435 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-058496 · doc4.xml · nonDerivative · entry 1 Key John P. · CIK 0001772458 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,099 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest in equal quarterly increments over a one year period, subject to the Reporting Person's continued service as of each such date. Read SEC document |
| December 12, 2023 Filed Dec 13, 2023 21:42 UTC |
McCarthy Mary PatDirector
|
GrantCommon Stock | 1,399 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-058498 · doc4.xml · nonDerivative · entry 1 McCarthy Mary Pat · CIK 0001565570 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,517 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest in equal quarterly increments over a one year period, subject to the Reporting Person's continued service as of each such date. Read SEC document |
| December 12, 2023 Filed Dec 13, 2023 21:43 UTC |
Twohill LorraineDirector
|
GrantCommon Stock | 1,326 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-058500 · doc4.xml · nonDerivative · entry 1 Twohill Lorraine · CIK 0001539925 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,246 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest in equal quarterly increments over a one year period, subject to the Reporting Person's continued service as of each such date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.